Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 202
1996 261
1997 351
1998 397
1999 554
2000 640
2001 595
2002 521
2003 814
2004 1096
2005 1151
2006 1026
2007 1006
2008 1053
2009 978
2010 759
2011 899
2012 805
2013 845
2014 836
2015 928
2016 1014
2017 956
2018 902
2019 973
2020 785
Text availability
Article attribute
Article type
Publication date

Search Results

18,697 results
Results by year
Filters applied: . Clear all
Page 1
Radiotherapy and Immunotherapy for Cancer: From "Systemic" to "Multisite".
Arina A, Gutiontov SI, Weichselbaum RR. Arina A, et al. Clin Cancer Res. 2020 Jun 15;26(12):2777-2782. doi: 10.1158/1078-0432.CCR-19-2034. Epub 2020 Feb 11. Clin Cancer Res. 2020. PMID: 32047000 Review.
Single-Cell Genomic Characterization Reveals the Cellular Reprogramming of the Gastric Tumor Microenvironment.
Sathe A, Grimes SM, Lau BT, Chen J, Suarez C, Huang RJ, Poultsides G, Ji HP. Sathe A, et al. Clin Cancer Res. 2020 Jun 1;26(11):2640-2653. doi: 10.1158/1078-0432.CCR-19-3231. Epub 2020 Feb 14. Clin Cancer Res. 2020. PMID: 32060101
Pathologic Complete Response after Neoadjuvant Chemotherapy and Impact on Breast Cancer Recurrence and Survival: A Comprehensive Meta-analysis.
Spring LM, Fell G, Arfe A, Sharma C, Greenup R, Reynolds KL, Smith BL, Alexander B, Moy B, Isakoff SJ, Parmigiani G, Trippa L, Bardia A. Spring LM, et al. Clin Cancer Res. 2020 Jun 15;26(12):2838-2848. doi: 10.1158/1078-0432.CCR-19-3492. Epub 2020 Feb 11. Clin Cancer Res. 2020. PMID: 32046998
Non-BRCA DNA Damage Repair Gene Alterations and Response to the PARP Inhibitor Rucaparib in Metastatic Castration-Resistant Prostate Cancer: Analysis From the Phase II TRITON2 Study.
Abida W, Campbell D, Patnaik A, Shapiro JD, Sautois B, Vogelzang NJ, Voog EG, Bryce AH, McDermott R, Ricci F, Rowe J, Zhang J, Piulats JM, Fizazi K, Merseburger AS, Higano CS, Krieger LE, Ryan CJ, Feng FY, Simmons AD, Loehr A, Despain D, Dowson M, Green F, Watkins SP, Golsorkhi T, Chowdhury S. Abida W, et al. Clin Cancer Res. 2020 Jun 1;26(11):2487-2496. doi: 10.1158/1078-0432.CCR-20-0394. Epub 2020 Feb 21. Clin Cancer Res. 2020. PMID: 32086346 Free article.
Antigen Experienced T Cells from Peripheral Blood Recognize p53 Neoantigens.
Malekzadeh P, Yossef R, Cafri G, Paria BC, Lowery FJ, Jafferji M, Good ML, Sachs A, Copeland AR, Kim SP, Kivitz S, Parkhurst MR, Robbins PF, Ray S, Xi L, Raffeld M, Yu Z, Restifo NP, Somerville RPT, Rosenberg SA, Deniger DC. Malekzadeh P, et al. Clin Cancer Res. 2020 Mar 15;26(6):1267-1276. doi: 10.1158/1078-0432.CCR-19-1874. Epub 2020 Jan 29. Clin Cancer Res. 2020. PMID: 31996390 Free PMC article.
PD-1/PD-L1 Blockers in NSCLC Brain Metastases: Challenging Paradigms and Clinical Practice.
Eguren-Santamaria I, Sanmamed MF, Goldberg SB, Kluger HM, Idoate MA, Lu BY, Corral J, Schalper KA, Herbst RS, Gil-Bazo I. Eguren-Santamaria I, et al. Clin Cancer Res. 2020 Aug 15;26(16):4186-4197. doi: 10.1158/1078-0432.CCR-20-0798. Epub 2020 Apr 30. Clin Cancer Res. 2020. PMID: 32354698 Review.
Identification of Deleterious NOTCH Mutation as Novel Predictor to Efficacious Immunotherapy in NSCLC.
Zhang K, Hong X, Song Z, Xu Y, Li C, Wang G, Zhang Y, Zhao X, Zhao Z, Zhao J, Huang M, Huang D, Qi C, Gao C, Cai S, Gu F, Hu Y, Xu C, Wang W, Lou Z, Zhang Y, Liu L. Zhang K, et al. Clin Cancer Res. 2020 Jul 15;26(14):3649-3661. doi: 10.1158/1078-0432.CCR-19-3976. Epub 2020 Apr 2. Clin Cancer Res. 2020. PMID: 32241817 Free article.
Oncogenic Genomic Alterations, Clinical Phenotypes, and Outcomes in Metastatic Castration-Sensitive Prostate Cancer.
Stopsack KH, Nandakumar S, Wibmer AG, Haywood S, Weg ES, Barnett ES, Kim CJ, Carbone EA, Vasselman SE, Nguyen B, Hullings MA, Scher HI, Morris MJ, Solit DB, Schultz N, Kantoff PW, Abida W. Stopsack KH, et al. Clin Cancer Res. 2020 Jul 1;26(13):3230-3238. doi: 10.1158/1078-0432.CCR-20-0168. Epub 2020 Mar 27. Clin Cancer Res. 2020. PMID: 32220891
Dissecting the Tumor-Immune Landscape in Chimeric Antigen Receptor T-cell Therapy: Key Challenges and Opportunities for a Systems Immunology Approach.
Chen GM, Azzam A, Ding YY, Barrett DM, Grupp SA, Tan K. Chen GM, et al. Clin Cancer Res. 2020 Jul 15;26(14):3505-3513. doi: 10.1158/1078-0432.CCR-19-3888. Epub 2020 Mar 3. Clin Cancer Res. 2020. PMID: 32127393 Free article. Review.
Macrophage HIF-1α Is an Independent Prognostic Indicator in Kidney Cancer.
Cowman SJ, Fuja DG, Liu XD, Tidwell RSS, Kandula N, Sirohi D, Agarwal AM, Emerson LL, Tripp SR, Mohlman JS, Stonhill M, Garcia G, Conley CJ, Olalde AA, Sargis T, Ramirez-Torres A, Karam JA, Wood CG, Sircar K, Tamboli P, Boucher K, Maughan B, Spike BT, Ho TH, Agarwal N, Jonasch E, Koh MY. Cowman SJ, et al. Clin Cancer Res. 2020 Sep 15;26(18):4970-4982. doi: 10.1158/1078-0432.CCR-19-3890. Epub 2020 Jun 25. Clin Cancer Res. 2020. PMID: 32586940
18,697 results
Jump to page
Feedback